List of Oral Presentations

The following Oral Presentations will be delivered at Infectious Diseases 2018:

Speaker Title Institution Country
Gerardo E. Guillén, PhD. Pending Title Center for Genetic Engineering and Biotechnology, CIGB Cuba
Beat H. Meier, Prof. Solid-state NMR of two nonstructural proteins of Hepatitis C Full Professor of Physical Chemistry Federal Institute of Technology in Zurich, Switzerland switzerland
Anja Bockmann, PhD Solid-state NMR investigation of capsids and envelopes from the Hepatitis B particle Directeur de recherches, Institut de Biologie et Chimie des Protéines, Lyon, France France
Lázaro Gil González, PhD An update on Cuban Dengue Vaccine Candidates Center for Genetic Engineering and Biotechnology, CIGB Cuba
María G. Guzmán, Prof. Pending Title Director of Center for Research, Diagnosis and Reference.Institute for Tropical Medicine Pedro Kouri Cuba
Julio C Aguilar, PhD. HEBERNASVAC, crossroad of biotechnology, vaccinology and liver immunology Head of Hepatitis B Vaccine Group, Vaccine Department, CIGB Cuba
Enrique Iglesias, Prof. Pending Title Center for Genetic Engineering and Biotechnology, CIGB Cuba

Frédéric Tangy, Dr.

Development of live measles vaccine vector to prevent new emerging viral diseases Department of Virology
Institute Pasteur, Paris, France
France

Immo Weichert , Dr.

Pending Title Acute Physician, The Ipswich Hospital NHS Trust, Ipswich, Suffolk, UK UK

Victor García , Dr.

Pending Title Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, NC, USA UK

Celia Fernandez-Ortega , Dr.

A peptide that penetrates human cell lines inhibits the HIV replication through the modulation of vimentin Center for Genetic Engineering and Biotechnology, La Habana, Cuba UK

Monsef Benkirane

Pending Title The Institute of Human Genetics, Montpelier, France UK

Oliver G. Perez

Challenging the adjuvant´s Gaston definition President of the Cuban Society of Immunology, Cuba UK

Diana Leticia Coronel Martínez

Dengvaxia Vaccine: Update September 2018 Regional Director of Clinical Science, Sanofi Pasteur UK

Dr. Vivian Huerta

Dengue virus interactome in human plasma reveals a novel target to develop antiviral drugs against the viral complex Center for Genetic Engineering and Biotechnology, La Habana, Cuba UK

Prof. Eduardo Pentón

Clinical trials of Chronic Hepatitis B therapeutic vaccines and novel therapeutic agents under clinical development Center for Genetic Engineering and Biotechnology, La Habana, Cuba UK

Dr. Jorge Aguiar

Robustness of a low cost HBV-DNA quantitative system, a potential partner in the introduction and follow-up of a novel therapeutic vaccine versus chronic hepatitis B Center for Genetic Engineering and Biotechnology, La Habana, Cuba UK

Dr. Guillermo Fernández

Five year follow-up of chronic hepatitis B patients immunized by nasal route with the therapeutic vaccine HeberNasvac Center for Genetic Engineering and Biotechnology, La Habana, Cuba UK

MSc. Santa M Olivera

Hepatitis C preventive vaccine based on a chimeric protein strategy Center for Genetic Engineering and Biotechnology, La Habana, Cuba UK

Dr. Annele Roque

Plants and marine algae as alternatives sources for antiviral drugs Vice Dean for Academic Affairs Faculty of Biology University of Havana UK